Bio-Rad Laboratories (BIO-B) Change in Cash (2009 - 2026)

Bio-Rad Laboratories (BIO-B) has 18 years of Change in Cash data on file, last reported at -$23.2 million in Q1 2026.

• Change in Cash for Q1 2026 came in at -$23.2 million, down 169.67% year-over-year; the trailing twelve-month figure through Mar 2026 was -$14.1 million (down 115.79% YoY), and the FY2025 annual result was $42.4 million, down 50.35% from the prior year.
• Change in Cash declined to -$23.2 million in Q1 2026 per BIO-B's latest filing, from $134.0 million in the prior quarter.
• Over five years, Change in Cash peaked at $331.5 million in Q1 2022 and troughed at -$205.7 million in Q2 2022.
• A 5-year average of $2.2 million and a median of $4.5 million in 2024 frame the typical range for Change in Cash.
• The sharpest annual moves came in 2022 and 2025: Change in Cash surged 3030.82% in 2022, then plunged 480.08% in 2025.
• A 5-year view of Change in Cash shows it stood at -$83.7 million in 2022, then soared by 35.65% to -$53.9 million in 2023, then surged by 244.05% to $77.6 million in 2024, then soared by 72.68% to $134.0 million in 2025, then slumped by 117.31% to -$23.2 million in 2026.
• Business Quant data shows BIO-B's Change in Cash at -$23.2 million in Q1 2026, $134.0 million in Q4 2025, and $26.5 million in Q3 2025.